Bids Are Invited For Procurement Of Everolimus 0.5 Mg Drug For Hsj

1º That The Ministry Of Health Is Responsible For Exercising The Function That Corresponds To The State Of Guaranteeing Free And Equal Access To Actions For The Promotion, Protection And Recovery Of Health And Rehabilitation Of The Sick Person; As Well As Coordinate, Control And, When Appropriate, Execute Such Actions. For Its Part, The San José Hospital Is A Network Self-Management Establishment, Functionally Deconcentrated, Whose Mission Is To Carry Out The Health Actions Entrusted To It. 2. That, In Accordance With The Provisions Of Exempt Resolution No. 443, Dated January 26, 2026, Which Approves The Annual Purchasing And Contracting Plan For The Year 2026 For The San José Hospital Complex, The Acquisition Of Drugs Code 214-4380 Everolimus 0.5 Mg Is Required. 3. That The Required Drug Is Not Found In The Catalog Of The Framework Agreement, Provided In The State Purchasing And Contracting Information And Management System, According To The Certificate Issued By The Procurement Headquarters Of The San José Hospital, Dated May 13, 2026, In Accordance With The Provisions Of Article 35 Bis, Second Paragraph, Of Law No. 19,886 And Article 29 Of The Regulations Of The Purchasing Law. 4. That, In The Case Of Goods That, Due To Their Nature, Cannot Be Reused Or Shared, In Accordance With The Provisions Of Article 28, Second Paragraph, Of The Regulations Of The Purchasing Law, The San José Hospital Is Exempt From The Consultation Procedure With The Circular Economy Platform. 5. That The Required Drug Is Not Intermediated, Because The Supplier Awarded In The Cenabast Tender Does Not Offer With Measurement Of Plasma Levels, Required By The Hospital And In Addition Each Of The Presentations Are Awarded To Different Suppliers And Awarding Is Required To A Single Supplier To Ensure The Stability Of Plasma Levels In Those Patients Who Require More Than One Presentation.